Approaches to Tumor Classification in Pulmonary Sarcomatoid Carcinoma

Código QR

Approaches to Tumor Classification in Pulmonary Sarcomatoid Carcinoma

Chiara Baldovini,1 Giulio Rossi,1 Alessia Ciarrocchi2 1Operative Unit of Pathologic Anatomy, Azienda USL della Romagna, Hospital S. Maria delle Croci, Ravenna, Italy; 2Laboratory of Translational Research, Azienda Unità Sanitaria Locale - IRCCS Reggio Emilia, Reggio Emilia 42123, ItalyCor...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Baldovini C, Rossi G, Ciarrocchi A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	sarcomatoid carcinoma c-met pd-l1 cytokeratins immunohistochemistry who Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/c46920986d4a4809b5015bd24ef31daf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

CARCINOMA SARCOMATOIDE MONOFÁSICO DE MAMA: CASO CLÍNICO
por: Carballo N,Elba, et al.
Publicado: (2011)

Thoracic mesenchymal malignant tumors and programed cell death ligand‐1 status: Clinicopathologic and prognostic analysis of eight pulmonary sarcomatoid carcinomas and eight malignant mesotheliomas
por: Kanji Otsubo, et al.
Publicado: (2021)

Knowledge of cytogenetic analysis for synovial sarcoma in sarcomatoid variant renal cell carcinoma
por: Vishal Farid Raza, et al.
Publicado: (2021)

Atypical Presentation of Spindle Cell Carcinoma
por: Harshika Singh, et al.
Publicado: (2021)

Rapidly Progressive Lung Sarcomatoid Carcinoma Managed with Doxorubicin Plus Ifosfamide and Pemetrexed
por: Jan Alberto Paredes Mogica, et al.
Publicado: (2021)

Orthogonal MET analysis in a population‐representative stage II–III colon cancer cohort: prognostic and potential therapeutic implications
por: Stephanie G. Craig, et al.
Publicado: (2021)

Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data
por: Florian Janisch, et al.
Publicado: (2021)

Keratinocytes differentiation and wound healing in rats with streptozotocin – induced diabetes and severe hyperglycemia
por: Evgeniy V. Ivanov, et al.
Publicado: (2020)

Prognostic relevance of longitudinal HGF levels in serum of patients with ovarian cancer
por: Daniel Martin Klotz, et al.
Publicado: (2021)

Efficacy and Safety of PD-1 Inhibitor Combined with Anlotinib on Advanced Neuroendocrine Carcinoma
por: YU Xuxu, et al.
Publicado: (2021)

Programmed Death-Ligand 1 Expression in Breast Cancer Patients: Clinicopathological Associations from a Single-Institution Study
por: Ayoub NM, et al.
Publicado: (2021)

c-Met-Specific Chimeric Antigen Receptor T Cells Demonstrate Anti-Tumor Effect in c-Met Positive Gastric Cancer
por: Chung Hyo Kang, et al.
Publicado: (2021)

Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
por: Xiangdong Ye, et al.
Publicado: (2021)

The Classification of Myeloproliferative Neoplasms: Rationale, Historical Background and Future Perspectives with Focus on Unclassifiable Cases
por: Marco Pizzi, et al.
Publicado: (2021)

Immunotherapy in Non-Small Cell Lung Cancer With Actionable Mutations Other Than EGFR
por: Karan Seegobin, et al.
Publicado: (2021)

Duodenal Metastasis of Pulmonary Pleomorphic Carcinoma: A Case Report
por: Masayuki Matsuda, et al.
Publicado: (2021)

Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
por: Pei-Yi Chu, et al.
Publicado: (2021)

A CT-Based Radiomics Nomogram Integrated With Clinic-Radiological Features for Preoperatively Predicting WHO/ISUP Grade of Clear Cell Renal Cell Carcinoma
por: Yingjie Xv, et al.
Publicado: (2021)

Application of PD-L1, PD-L2, CD30, CD23 and BCL-6 in Diagnosis and Prognostic Evaluation of Primary Mediastinal Large B-cell Lymphoma
por: YUAN Ting, et al.
Publicado: (2021)

PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis
por: Xinxin Zhu, et al.
Publicado: (2021)

Prognostic Significance of PD-L1 Expression In Patients With Primary Oropharyngeal Squamous Cell Carcinoma: A Meta-Analysis
por: Jerry Polesel, et al.
Publicado: (2021)

Relation Between Tumor Budding and Endoscopic Classification, Degree of Malignancy in T1 Stage Esophageal Squamous Cell Carcinoma
por: WANG Kang, et al.
Publicado: (2021)

Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma?
por: Chao-Wei Lee, et al.
Publicado: (2021)

Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity
por: Ling Ding, et al.
Publicado: (2021)

Comprehensive molecular profiling of pulmonary pleomorphic carcinoma
por: Masaaki Nagano, et al.
Publicado: (2021)

E-cadherin and c-Met expression in actinic cheilits and lip squamous cell carcinoma
por: Martínez,A, et al.
Publicado: (2011)

Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor
por: Hao Chen, et al.
Publicado: (2021)

PD-1 blockade improves the anti-tumor potency of exhausted CD3+CD56+ NKT-like cells in patients with primary hepatocellular carcinoma
por: Longxiang Tao, et al.
Publicado: (2021)

FTIR Spectroscopic Imaging Supports Urine Cytology for Classification of Low- and High-Grade Bladder Carcinoma
por: Monika Kujdowicz, et al.
Publicado: (2021)

Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis
por: Silvia González-Martínez, et al.
Publicado: (2021)

Sebaceous Carcinoma – Unexpected Tumor of the Nasal Ala Dorsum
por: Vlaykov At., et al.
Publicado: (2019)

Anti-PD-1 Immunotherapy Combined With Stereotactic Body Radiation Therapy and GM-CSF as Salvage Therapy in a PD-L1-Positive Patient With Refractory Metastatic Thyroid Hürthle Cell Carcinoma: A Case Report and Literature Review
por: Haihua He, et al.
Publicado: (2021)

Progression in Ph-Chromosome-Negative Myeloproliferative Neoplasms: An Overview on Pathologic Issues and Molecular Determinants
por: Elena Sabattini, et al.
Publicado: (2021)

Risco de Recorrência do Carcinoma Hepatocelular após o Uso de Antivirais de Ação Direta no Tratamento de Hepatite C: Revisão Sistemática e Metanálise
por: Jefferson Wrublack Cuba, et al.
Publicado: (2021)

Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer—A New Diagnostic and Therapeutic Target?
por: Sabine Wächter, et al.
Publicado: (2021)

Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
por: Kimberly M. Burcher, et al.
Publicado: (2021)

Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy
por: Yang Z, et al.
Publicado: (2018)

Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits
por: Chiara Giacomelli, et al.
Publicado: (2021)

Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients
por: Juliette Palle, et al.
Publicado: (2021)

Elevated DNA Polymerase Delta 1 Expression Correlates With Tumor Progression and Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma
por: Shuai Zhao, et al.
Publicado: (2021)